Therefore, this study studied the inhibition of TLR4 by regulating PDK1-induced metabolic reprogramming and inhibiting the inflammatory response in inflammatory bowel disease (IBD) in a m6A-dependent manner. Here, PDK1 is linked to inflammatory bowel disease.